U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H27N3O2
Molecular Weight 269.3831
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PRAMIRACETAM

SMILES

CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C

InChI

InChIKey=ZULJGOSFKWFVRX-UHFFFAOYSA-N
InChI=1S/C14H27N3O2/c1-11(2)17(12(3)4)9-7-15-13(18)10-16-8-5-6-14(16)19/h11-12H,5-10H2,1-4H3,(H,15,18)

HIDE SMILES / InChI

Molecular Formula C14H27N3O2
Molecular Weight 269.3831
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:45:44 UTC 2023
Edited
by admin
on Sat Dec 16 17:45:44 UTC 2023
Record UNII
4449F8I3LE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PRAMIRACETAM
INN   MI   WHO-DD  
INN  
Official Name English
N-(2-(DIISOPROPYLAMINO)ETHYL)-2-OXO-1-PYRROLIDINEACETAMIDE
Systematic Name English
pramiracetam [INN]
Common Name English
PRAMIRACETAM [MI]
Common Name English
1-PYRROLIDINEACETAMIDE, N-(2-(BIS(1-METHYLETHYL)AMINO)ETHYL)-2-OXO-
Systematic Name English
CI-879 FREE BASE
Code English
Pramiracetam [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1509
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
WHO-ATC N06BX16
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
WHO-VATC QN06BX16
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
Code System Code Type Description
MESH
C038438
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
EPA CompTox
DTXSID60218604
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
DRUG CENTRAL
2234
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
INN
5054
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
EVMPD
SUB09991MIG
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
SMS_ID
100000081394
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
CAS
68497-62-1
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
WIKIPEDIA
PRAMIRACETAM
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
FDA UNII
4449F8I3LE
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
NCI_THESAURUS
C84171
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
MERCK INDEX
m9096
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY Merck Index
ChEMBL
CHEMBL159776
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
PUBCHEM
51712
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
DRUG BANK
DB13247
Created by admin on Sat Dec 16 17:45:45 UTC 2023 , Edited by admin on Sat Dec 16 17:45:45 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
TARGET->POSITIVE ALLOSTERIC MODULATOR (PAM)
Low-impact AMPAR PAMs decrease AMPAR deactivation (channel closing) alone to augment synaptic currents.
Related Record Type Details
ACTIVE MOIETY